Reuters logo
BRIEF-Veracyte announces release of 2018 preliminary reimbursement rate for Afirma Genomic Classifier under PAMA
September 25, 2017 / 12:30 PM / 24 days ago

BRIEF-Veracyte announces release of 2018 preliminary reimbursement rate for Afirma Genomic Classifier under PAMA

Sept 25 (Reuters) - Veracyte Inc

* Veracyte Inc - reimbursement rate for Afirma Genomic Classifier is expected to increase from $3,220 to $3,600 for calendar year 2018

* Veracyte - CMS plans to finalize rates in Nov 2017, following a public comment period, and new rates are scheduled to become effective Jan. 1, 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below